Zacks Research Estimates McKesson’s Q2 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Investment analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for shares of McKesson in a research note issued on Tuesday, October 22nd. Zacks Research analyst R. Department now forecasts that the company will earn $6.97 per share for the quarter, down from their prior forecast of $7.11. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Zacks Research also issued estimates for McKesson’s Q3 2025 earnings at $8.24 EPS, Q4 2025 earnings at $8.88 EPS, FY2025 earnings at $31.97 EPS, Q1 2026 earnings at $7.86 EPS, Q3 2026 earnings at $9.85 EPS and Q4 2026 earnings at $8.95 EPS.

MCK has been the topic of a number of other reports. Baird R W cut McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 24th. JPMorgan Chase & Co. raised their price objective on shares of McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Robert W. Baird restated a “neutral” rating and set a $531.00 target price (down previously from $603.00) on shares of McKesson in a research report on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft reduced their price target on McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research report on Wednesday, September 25th. Finally, Wells Fargo & Company dropped their price objective on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a report on Friday, September 13th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $610.86.

McKesson Stock Up 0.6 %

Shares of MCK stock opened at $504.96 on Thursday. McKesson has a 12-month low of $431.35 and a 12-month high of $637.51. The company has a 50 day moving average of $518.29 and a 200-day moving average of $551.37. The firm has a market cap of $65.61 billion, a P/E ratio of 22.56, a PEG ratio of 1.17 and a beta of 0.44.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.21 by $0.67. The company had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $7.27 earnings per share.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were paid a dividend of $0.71 per share. The ex-dividend date was Friday, August 30th. This represents a $2.84 annualized dividend and a yield of 0.56%. This is a positive change from McKesson’s previous quarterly dividend of $0.62. McKesson’s payout ratio is 12.69%.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the sale, the chief executive officer now owns 78,586 shares of the company’s stock, valued at $44,094,604.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.11% of the company’s stock.

Institutional Investors Weigh In On McKesson

Institutional investors have recently made changes to their positions in the business. RFP Financial Group LLC raised its position in McKesson by 9.8% in the 2nd quarter. RFP Financial Group LLC now owns 191 shares of the company’s stock worth $112,000 after purchasing an additional 17 shares during the period. Modera Wealth Management LLC lifted its stake in shares of McKesson by 2.2% in the 2nd quarter. Modera Wealth Management LLC now owns 804 shares of the company’s stock valued at $470,000 after acquiring an additional 17 shares during the last quarter. Larson Financial Group LLC boosted its holdings in McKesson by 1.6% during the 2nd quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $639,000 after acquiring an additional 17 shares during the period. First Western Trust Bank grew its position in McKesson by 2.0% during the 1st quarter. First Western Trust Bank now owns 913 shares of the company’s stock worth $490,000 after acquiring an additional 18 shares during the last quarter. Finally, KCM Investment Advisors LLC increased its stake in McKesson by 1.4% in the 1st quarter. KCM Investment Advisors LLC now owns 1,355 shares of the company’s stock worth $727,000 after purchasing an additional 19 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.